Home
Jeffrey W. Albers, Director: Blueprint Medicines BPMC Sell · Filed 25/01/23
Trade details
- Type
- Insider sale
- Amount
- $824,980.71
- Shares · price
- 7,561 sh · $109.11 a share
- Held after
- 159,996 sh
- Trade date
- 25/01/21
- Filed
- 25/01/23
- Days to filing
- 2 days
Sold 4.5% of holdings
- Share of holding sold
- 4.5%
Blueprint Medicines trades, last 26 weeks
What else happened in Blueprint Medicines around then
Filed or reported within 30 days of the trade day · 24/12/22~25/02/20Jeffrey W. Albers's recent trades
- Jeffrey W. Albers
Planned sale10b5-1 planSpyre Therapeutics
Planned sale10b5-1 planSpyre Therapeutics
SYRE
$517.1K
5,000 sh
$517.1K
Filed 08/07
Traded 08/07
- Jeffrey W. Albers
Planned sale10b5-1 planSpyre Therapeutics
Planned sale10b5-1 planSpyre Therapeutics
SYRE
$1.9M
18,000 sh
$1.9M
Filed 08/07
Traded 08/07
- Jeffrey W. Albers
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 planKymera Therapeutics
KYMR
$245.5K
2,748 sh
$245.5K
Filed 25/12/08
Traded 25/12/08
- Jeffrey W. Albers
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 planKymera Therapeutics
KYMR
$203.4K
2,252 sh
$203.4K
Filed 25/12/08
Traded 25/12/08
- Jeffrey W. Albers
Planned sale10b5-1 planKymera Therapeutics
Planned sale10b5-1 planKymera Therapeutics
KYMR
$333.1K
5,000 sh
$333.1K
Filed 25/12/08
Traded 25/12/08
